These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21680863)

  • 41. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hit finding: towards 'smarter' approaches.
    Langer T; Hoffmann R; Bryant S; Lesur B
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rules for identifying potentially reactive or promiscuous compounds.
    Bruns RF; Watson IA
    J Med Chem; 2012 Nov; 55(22):9763-72. PubMed ID: 23061697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hit Dexter: A Machine-Learning Model for the Prediction of Frequent Hitters.
    Stork C; Wagner J; Friedrich NO; de Bruyn Kops C; Šícho M; Kirchmair J
    ChemMedChem; 2018 Mar; 13(6):564-571. PubMed ID: 29285887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selectivity of kinase inhibitor fragments.
    Bamborough P; Brown MJ; Christopher JA; Chung CW; Mellor GW
    J Med Chem; 2011 Jul; 54(14):5131-43. PubMed ID: 21699136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Probing the primary screening efficiency by multiple replicate testing: a quantitative analysis of hit confirmation and false screening results of a biochemical assay.
    Zhang JH; Wu X; Sills MA
    J Biomol Screen; 2005 Oct; 10(7):695-704. PubMed ID: 16129776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-throughput, cell-free, liposome-based approach for assessing in vitro activity of lipid kinases.
    Demian DJ; Clugston SL; Foster MM; Rameh L; Sarkes D; Townson SA; Yang L; Zhang M; Charlton ME
    J Biomol Screen; 2009 Aug; 14(7):838-44. PubMed ID: 19641220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS Collection.
    Chakravorty SJ; Chan J; Greenwood MN; Popa-Burke I; Remlinger KS; Pickett SD; Green DVS; Fillmore MC; Dean TW; Luengo JI; Macarrón R
    SLAS Discov; 2018 Jul; 23(6):532-545. PubMed ID: 29699447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel potent inhibitors of deoxycytidine kinase identified and compared by multiple assays.
    Yu XC; Miranda M; Liu Z; Patel S; Nguyen N; Carson K; Liu Q; Swaffield JC
    J Biomol Screen; 2010 Jan; 15(1):72-9. PubMed ID: 19959816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiplex enzyme assays and inhibitor screening by mass spectrometry.
    Rathore R; Pribil P; Corr JJ; Seibel WL; Evdokimov A; Greis KD
    J Biomol Screen; 2010 Sep; 15(8):1001-7. PubMed ID: 20228278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.
    Dahlin JL; Nissink JWM; Francis S; Strasser JM; John K; Zhang Z; Walters MA
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4740-4752. PubMed ID: 26318992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of data integrity on decision making in early lead discovery.
    Beck B; Seeliger D; Kriegl JM
    J Comput Aided Mol Des; 2015 Sep; 29(9):911-21. PubMed ID: 26409840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing HTS performance using BioAssay Ontology: screening and analysis of a bacterial phospho-N-acetylmuramoyl-pentapeptide translocase campaign.
    Moberg A; Zander Balderud L; Hansson E; Boyd H
    Assay Drug Dev Technol; 2014; 12(9-10):506-13. PubMed ID: 25415593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statistical models for identifying frequent hitters in high throughput screening.
    Goodwin S; Shahtahmassebi G; Hanley QS
    Sci Rep; 2020 Oct; 10(1):17200. PubMed ID: 33057035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abbott Physicochemical Tiering (APT)--a unified approach to HTS triage.
    Cox PB; Gregg RJ; Vasudevan A
    Bioorg Med Chem; 2012 Jul; 20(14):4564-73. PubMed ID: 22727778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On the Relationship between Molecular Hit Rates in High-Throughput Screening and Molecular Descriptors.
    Hansson M; Pemberton J; Engkvist O; Feierberg I; Brive L; Jarvis P; Zander-Balderud L; Chen H
    J Biomol Screen; 2014 Jun; 19(5):727-37. PubMed ID: 23975880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies to generate biological reagents for kinase drug discovery.
    Hassan NJ; Gul S
    Expert Opin Drug Discov; 2011 Dec; 6(12):1215-25. PubMed ID: 22647062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.
    Inglese J; Auld DS; Jadhav A; Johnson RL; Simeonov A; Yasgar A; Zheng W; Austin CP
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11473-8. PubMed ID: 16864780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.